Assyro AI

Orange Book product · Brand (NDA)

QVAR 40

BECLOMETHASONE DIPROPIONATE

Brand (NDA)NDA 020911DISCN TEVA BRANDED PHARM

At a glance

Sep 15, 2000

Approved

Brand (NDA)

Application

Not listed

TE code

5

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 15, 2000

    26 yr 2 mo ago

  2. Today

  3. Patent 10022509 expires

    Listed drug product patent expiration.

    May 18, 2031

    in 5 yr

  4. Patent 10022510 expires

    Listed drug product patent expiration.

    May 18, 2031

    in 5 yr

  5. Patent 10086156 expires

    Listed drug product patent expiration.

    May 18, 2031

    in 5 yr

  6. Patent 9463289 expires

    Listed drug product patent expiration.

    May 18, 2031

    in 5 yr

  7. Patent 9808587 expires

    Listed drug product patent expiration.

    May 18, 2031

    in 5 yr

Pharmaceutical detail

Active ingredient

BECLOMETHASONE DIPROPIONATE

Strength

0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

AEROSOL, METERED

Route

INHALATION

TE code

Not listed

Application

NDA 020911

Product number

002

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10022509May 18, 2031in 5 yr
ProductDelisted
10022510May 18, 2031in 5 yr
ProductDelisted
10086156May 18, 2031in 5 yr
ProductDelisted
9463289May 18, 2031in 5 yr
ProductDelisted
9808587May 18, 2031in 5 yr
ProductDelisted
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.